|
| 37543656 | Novel non-MRI imaging techniques for primary diagnosis of prostate cancer: micro-ultrasound, contrast-enhanced ultrasound, elastography, multiparametric ultrasound, and PSMA PET/CT. | Prostate Cancer Prostatic Dis | 2024 |
| 34602360 | Should men undergo MRI before prostate biopsy - CON. | Urologic Oncology: Seminars and Original Investigations | 2023 |
| 37945903 | Characterizing prostate cancer risk through multi-ancestry genome-wide discovery of 187 novel risk variants. | Nat Genet | 2023 |
| 37070723 | Smoking and lower urinary tract symptoms in Reduction by Dutasteride of Prostate Cancer Events Trial. | Prostate | 2023 |
| 37121865 | Impact of F-fluciclovine PET/CT on plans for androgen deprivation therapy in patients with biochemical recurrence of prostate cancer: data analysis from two prospective clinical trials. | | 2023 |
| 35085038 | Survival Outcomes in Men with Unfavorable Intermediate-Risk and High-Risk Prostate Cancer Treated with Prostate-Only versus Whole Pelvic Radiation Therapy. | J Urol | 2022 |
| 35849143 | Acetylated HOXB13 Regulated Super Enhancer Genes Define Therapeutic Vulnerabilities of Castration-Resistant Prostate Cancer. | Clin Cancer Res | 2022 |
| 36355389 | Antiandrogen Treatment vs Active Surveillance for Patients With Prostate Cancer. | JAMA Oncology | 2022 |
| 35282697 | Reply by Authors. | J Urol | 2022 |
| 34728381 | Optimization of prostate biopsy - Micro-Ultrasound versus MRI (OPTIMUM): A 3-arm randomized controlled trial evaluating the role of 29⿯MHz micro-ultrasound in guiding prostate biopsy in men with clinical suspicion of prostate cancer. | Contemp Clin Trials | 2022 |
| 35246608 | Liquid biomarkers for early detection of prostate cancer and summary of available data for their use in African-American men. | Prostate Cancer and Prostatic Diseases | 2022 |
| 34433304 | Prospective Multicenter Comparison of Open and Robotic Radical Prostatectomy: The PROST-QA/RP2 Consortium. | J Urol | 2022 |
| 35166438 | The impact of smoking on sexual function. | BJU Int | 2022 |
| 34544265 | Statin Use and Lower Urinary Tract Symptoms Incidence and Progression in Reduction by Dutasteride of Prostate Cancer Events (REDUCE) Trial. | J Urol | 2022 |
| 34933753 | Antiadenovirus Antibodies Predict Response Durability to Nadofaragene Firadenovec Therapy in BCG-unresponsive Non-muscle-invasive Bladder Cancer: Secondary Analysis of a Phase 3 Clinical Trial. | Eur Urol | 2022 |
| 33398198 | Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction. | Nat Genet | 2021 |
| 31965406 | Partial Validation of the Sleep Health Construct in the Medical Outcomes Study Sleep Questionnaire. | J Clin Psychol Med Settings | 2021 |
| 33473200 | Publisher Correction: Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction. | Nat Genet | 2021 |
| 33939794 | Smoking Is Associated With Basal Cell Hyperplasia on Prostate Biopsy Specimens. | Am J Clin Pathol | 2021 |
| 33773592 | Body size throughout the life-course and incident benign prostatic hyperplasia-related outcomes and nocturia. | BMC Urol | 2021 |
| 33771855 | Single-cell Spatial Proteomic Revelations on the Multiparametric MRI Heterogeneity of Clinically Significant Prostate Cancer. | Clin Cancer Res | 2021 |
| 33605791 | Dutasteride Improves Nocturia but Does Not Lead to Better Sleep: Results from the REDUCE Clinical Trial. | J Urol | 2021 |
| 34186135 | Prostate Cancer Incidence and Mortality Following a Negative Biopsy in a Population Undergoing PSA Screening. | Urology | 2021 |
| 34136665 | Does the sequence of high-dose rate brachytherapy boost and IMRT for prostate cancer impact early toxicity outcomes? Results from a single institution analysis. | Clin Transl Radiat Oncol | 2021 |
| 33253641 | Intravesical nadofaragene firadenovec gene therapy for BCG-unresponsive non-muscle-invasive bladder cancer: a single-arm, open-label, repeat-dose clinical trial. | Lancet Oncol | 2021 |
| 33353869 | Factors associated with higher prostate biopsy yield: when is software-assisted fusion MRI-targeting necessary? | Urologic Oncology: Seminars and Original Investigations | 2021 |
| 33080149 | Chronic Baseline Prostate Inflammation is Associated with Lower Tumor Grade in Men with Prostate Cancer on Repeat Biopsy: Results from the REDUCE Study. | J Urol | 2021 |
| 33347771 | Does Pollen Trigger Urological Chronic Pelvic Pain Syndrome Flares? A Case-Crossover Analysis in the Multidisciplinary Approach to the Study of Chronic Pelvic Pain Research Network. | J Urol | 2021 |
| 33160848 | Prostate cancer recurrence in patients with negative or equivocal conventional imaging: A role for F-fluciclovine-PET/CT in delineating sites of recurrence and identifying patients with oligometastatic disease. | Urologic Oncology: Seminars and Original Investigations | 2021 |
| 31479563 | Statin use and longitudinal changes in prostate volume; results from the REduction by DUtasteride of prostate Cancer Events (REDUCE) trial. | BJU Int | 2020 |
| 32065867 | Considerations and alternative approaches to antibiotic prophylaxis for prostate biopsy. | Canadian Journal of Urology | 2020 |
| 31733275 | Diagnostic Properties of Total and Free Prostate-Specific Antigen to Predict Overall and Clinically Significant Prostate Cancer Among Men With Low Testosterone and Prior Negative Biopsy. | Urology | 2020 |
| 32304677 | Commentary RE: "Efficacy and Safety of a Dual Inhibitor of 5-Alpha-Reductase Types 1 and 2 (Dutasteride) in Men With Benign Prostatic Hyperplasia". | Urology | 2020 |
| 33927572 | Low Penetrance Germline Genetic Testing: Role for Risk Stratification in Prostate Cancer Screening and Examples From Clinical Practice. | | 2020 |
| 33049187 | Evolving understanding and categorization of prostate cancer: preventing progression to metastatic castration-resistant prostate cancer: RADAR IV. | Can J Urol | 2020 |
| 32885168 | ACK1-AR and AR-HOXB13 signaling axes: epigenetic regulation of lethal prostate cancers. | NAR Cancer | 2020 |
| 33199816 | Natural bladder filling alters resting brain function at multiple spatial scales: a proof-of-concept MAPP Network Neuroimaging Study. | Sci Rep | 2020 |
| 32578257 | The Multidisciplinary Approach to The Study of Chronic Pelvic Pain (MAPP) Research Network*: Design and implementation of the Symptom Patterns Study (SPS). | Neurourol Urodyn | 2020 |
| 32856605 | Asian Race and Risk of Prostate Cancer: Results from the REDUCE Study. | Cancer Epidemiol Biomarkers Prev | 2020 |
| 32516092 | Implementation of Germline Testing for Prostate Cancer: Philadelphia Prostate Cancer Consensus Conference 2019. | J Clin Oncol | 2020 |
| 32893408 | Does weather trigger urologic chronic pelvic pain syndrome flares? A case-crossover analysis in the multidisciplinary approach to the study of the chronic pelvic pain research network. | Neurourol Urodyn | 2020 |
| 32833249 | Sleep quality and prostate cancer aggressiveness: Results from the REDUCE trial. | Prostate | 2020 |
| 30327280 | Accuracy and Variability of Prostate Multiparametric Magnetic Resonance Imaging Interpretation Using the Prostate Imaging Reporting and Data System: A Blinded Comparison of Radiologists. | European Urology Focus | 2020 |
| 31067347 | Metastatic prostate cancer at diagnosis and through progression in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. | Cancer | 2019 |
| 31674313 | What is the best PET target for early biochemical recurrence of prostate cancer? | Lancet Oncology, The | 2019 |
| 31880795 | Single-Nucleotide Polymorphism-Based Genetic Risk Score and Patient Age at Prostate Cancer Diagnosis. | JAMA Netw Open | 2019 |
| 30214036 | Nocturia and associated mortality: observational data from the REDUCE trial. | Prostate Cancer Prostatic Dis | 2019 |
| 29873889 | Both acute and chronic inflammation are associated with less perineural invasion in men with prostate cancer on repeat biopsy. | BJU Int | 2019 |
| 30580005 | Magnetic Resonance Imaging-Defined Prostate-Specific Antigen Density Significantly Improves the Risk Prediction for Clinically Significant Prostate Cancer on Biopsy. | Urology | 2019 |
| 30577401 | Editorial Comment. | Journal of Urology | 2019 |